Dr. Reddys Labs

Dr. Reddy’s Labs Q2 FY25 Results: Revenue grows 16.5% YoY to 8016 crore, Net Profit down 15.3% 

Dr Reddy’s share price rise post launch of COVID-19 drug

Nifty Pharma Index rises 5.8% to create 52 week high at 12,528 level, Dr. Reddys Labs touches Rs 5,497

Nifty Pharma Index was in the focus with the NSE Index rallying 5.8% touching 12,528 levels, creating the record high of 52 week today. It was led by major buying in Dr. Reddys Labs and Cipla contributing 235.85 and 112.14 points respectively.